Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
31.47
+1.33 (4.41%)
At close: Jun 26, 2026, 4:00 PM EDT
30.85
-0.62 (-1.97%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Tango Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Tango Therapeutics stock have an average target of 41.64, with a low estimate of 24 and a high estimate of 66. The average target predicts an increase of 32.32% from the current stock price of 31.47.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tango Therapeutics stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 10 | 9 | 11 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Upgrades $60 | Buy | Upgrades | $60 | +90.66% | Jun 25, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $32 | Buy | Maintains | $32 | +1.68% | Jun 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $27 → $66 | Buy | Reiterates | $27 → $66 | +109.72% | Jun 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $42 | Buy | Maintains | $42 | +33.46% | Jun 9, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $30 → $36 | Buy | Reiterates | $30 → $36 | +14.39% | Jun 8, 2026 |
Financial Forecast
Revenue This Year
n/a
from 62.38M
Decreased by -100.00%
Revenue Next Year
3.14M
EPS This Year
-1.32
from -0.87
EPS Next Year
-1.57
from -1.32
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 31.4M | |
| Avg | n/a | 3.1M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -100.0% | - | |
| Avg | -100.0% | - | |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.15 | -1.24 | |
| Avg | -1.32 | -1.57 | |
| Low | -1.44 | -1.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.